María Lourdes
Vázquez López
Profesora Asociada CC. Salud
Hospital de Jerez
Jerez, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Jerez (6)
2020
-
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Experimental Hematology and Oncology, Vol. 9, Núm. 1
-
Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in Spain (GETH-MIC)
Revista Espanola de Quimioterapia, Vol. 33, Núm. 2, pp. 110-115
2017
-
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial
The Lancet Haematology, Vol. 4, Núm. 12, pp. e573-e583
2008
-
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: The influence of prior exposure to rituximab on outcome. A GEL/TAMO study
Haematologica, Vol. 93, Núm. 12, pp. 1829-1836
1997
-
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors
Bone Marrow Transplantation, Vol. 20, Núm. 6, pp. 451-458